Sequence of mechanical, electrocardiographic and clinical effects of repeated coronary artery occlusion in human beings: echocardiographic observations during coronary angioplasty.

The direct manipulation of coronary blood flow to induce regional myocardial ischemia has been almost entirely limited to experimental animal models. Thus, the detection of ischemia-induced left ventricular dysfunction in human subjects has been generally limited to observations made under conditions of diagnostic loading or during spontaneous clinical events. Percutaneous coronary angioplasty requires repeated interruptions of coronary blood flow for periods as long as 1 minute. The resulting appearance of or increase in ischemia-produced changes in myocardial function were detected by two-dimensional echocardiography in 18 patients undergoing angioplasty of 22 coronary stenoses. Accordingly, left ventricular contraction was studied during 52 episodes of regional coronary blood flow interruption and reperfusion in the process of inflating and deflating the angioplasty balloon. Before angioplasty, left ventricular wall motion was normal in 14 patients. There was mild anteroapical hypokinesia in two patients, anteroapical akinesia in one and mild inferior hypokinesia in one. Balloon inflations repeatedly produced new or increased wall motion abnormalities in the distribution of the instrumented coronary artery in 19 (86.4%) of the 22 procedures, but did not alter wall motion during angioplasty of one left circumflex artery lesion, one highly collateralized left anterior descending artery stenosis and one left anterior descending stenosis that had already caused severe anteroapical dyssynergy. Hypokinesia, usually rapidly progressing to dyskinesia, began 19 +/- 8 seconds (mean +/- SD) after coronary occlusion. Wall motion began to normalize 17 +/- 8 seconds after reperfusion.(ABSTRACT TRUNCATED AT 250 WORDS)

Effect of peripheral cardiopulmonary bypass on left ventricular size, afterload and myocardial function during elective supported coronary angioplasty.

Although cardiopulmonary bypass support has been increasingly used for high risk coronary angioplasty, few data exist regarding its effects on left ventricular function. Accordingly, in 20 patients changes in left ventricular size, afterload and myocardial function were assessed by continuous hemodynamic monitoring and simultaneous two-dimensional echocardiography during cardiopulmonary bypass-supported high risk angioplasty. The cross-sectional left ventricular area during bypass support remained unchanged during diastole, whereas during systole it decreased (from 29.6 +/- 11.4 to 27.6 +/- 10.4 cm2, p less than 0.05). Global left ventricular function expressed as fractional area change remained unchanged from baseline to bypass support but decreased during balloon inflation (from 0.27 +/- 0.11 to 0.17 +/- 0.09, p less than 0.001). The end-systolic meridional wall stress decreased during bypass support (from 141 +/- 75 to 110 +/- 58 x 10(3) dynes/cm2, p less than 0.02). Regional myocardial function was assessed by a wall motion score (0 = normal, 1 = hypokinesia, 2 = akinesia and 3 = dyskinesia). Regions supplied by a stenotic (greater than or equal to 50% diameter) vessel deteriorated during bypass support (score from 0.9 +/- 0.8 to 1.06 +/- 0.8, p less than 0.01), whereas regions supplied by a nonstenotic vessel did not. Regions supplied by the target vessel deteriorated further during balloon inflation (score from 0.7 +/- 0.6 to 1.7 +/- 0.75, p less than 0.001). Thus, although left ventricular size and global function remain unchanged and afterload decreases during bypass support, myocardial dysfunction in regions supplied by a stenotic vessel may occur. Furthermore, regional and global left ventricular dysfunction still occur with angioplasty balloon inflation during cardiopulmonary bypass support.

The influence of infarction site and size on the ventricular response to coronary thrombolysis.

To test the hypothesis that myocardial infarction (MI) size rather than location determines the ventricular response to reperfusion, we studied 69 patients receiving intracoronary streptokinase within five hours of chest pain onset who displayed sustained reperfusion at 8.4 +/- 3.4 (SD) days. Twenty reperfusion failures served as controls. There were 31 patients with anterior MIs, 18 of which were estimated to be large based on an ejection fraction (EF) at reperfusion of less than 50%; 14 of 38 patients with inferior MIs also had large MIs. The EF increased at follow-up by 6.4% +/- 2.6% in patients with large anterior MIs and by 8.2% +/- 2.5% in those with large inferior MIs; in contrast, it increased by only 1.8% +/- 2.6% in patients with small anterior MIs and significantly decreased by 5.8% +/- 1.9% in patients with small inferior MIs. Six controls with large MIs (four anterior) displayed no change in EF; in 14 with small MIs (ten inferior), it fell slightly. There were no significant group differences in the number of diseased vessels, residual stenosis, or collaterals. It is concluded that MI size, not site, largely determines the ventricular functional response to early reperfusion; thus, patients with inferior MIs cannot be disqualified on this basis alone for thrombolytic therapy.

Hemorrhage vs rethrombosis after thrombolysis for acute myocardial infarction.

To determine whether or not the timing of heparin infusion affects either bleeding or reocclusion following intracoronary streptokinase for acute myocardial infarction, heparin was infused immediately after streptokinase in 89 patients and was delayed for 12 hours in the subsequent 93. Bleeding occurred in 22 immediate-heparin patients and was major in five (one fatal); there were 14 hemorrhages in the delayed-heparin group, all minor. At discharge, reocclusions were observed in 18% (12/68) of immediate-heparin patients, and 11% (3/27) of the latter. Bioassayed fibrinogen levels displayed sustained depression regardless of bleeding for 20 hours after streptokinase; however, defibrinogenation measured by immunoassay was much less striking. This suggests that high levels of fibrinogen degradation products spuriously affect the bioassay of fibrinogen. We conclude that bleeding is related to the anticoagulant effects of fibrinogen degradation products interacting with heparin, and may be largely independent of hypofibrinogenemia. Delaying heparin for 12 hours may decrease the risk of bleeding while little affecting the risk of reocclusion.

Clinical, hemodynamic, electrocardiographic and mechanical events during nonocclusive, coronary atherectomy and comparison with balloon angioplasty.

The periprocedural events and myocardial function during nonocclusive coronary atherectomy by Rotablator or transluminal extraction catheter (TEC) may differ from events during balloon angioplasty. This may have important clinical consequences and needs to be defined further. Therefore, 17 patients undergoing Rotablator and 18 undergoing TEC atherectomy were assessed by clinical, hemodynamic and electrocardiographic monitoring and simultaneous transesophageal echocardiography. The findings were compared with similar parameters during subsequent balloon angioplasty performed in 16 of 17 patients undergoing Rotablator and 14 of 18 undergoing TEC atherectomy. Chest pain occurred more frequently during balloon inflation than during either atherectomy (p less than 0.02), whereas ST-segment and T-wave electrocardiographic changes were equally frequent. Transient second- or third-degree atrioventricular block occurred in 6 patients during Rotablator but in none during TEC atherectomy or balloon inflation (p less than 0.01 for each). Hemodynamic parameters and global left ventricular function remained unchanged during atherectomy. Regional myocardial function in the distribution of the target coronary artery, assessed by a wall motion score, was not affected during Rotablator, but deteriorated slightly during TEC atherectomy and more significantly during balloon inflation (score from 0.3 +/- 0.5 to 1.0 +/- 0.7 during TEC and 2.0 +/- 0.6 during balloon inflation, p less than 0.005 for both). Thus, chest pain is infrequent, whereas hemodynamics and global left ventricular function are preserved during Rotablator and TEC atherectomy. Transient atrioventricular block during Rotablator and regional myocardial dysfunction during TEC atherectomy may occur without significant consequences. These data suggest that these techniques may be preferable to balloon angioplasty for preserving intraprocedural left ventricular function.

Value of transesophageal echocardiography during complex or high-risk coronary interventions in the cardiac catheterization laboratory.

The increasing complexity of coronary intervention and the limitations of hemodynamic and electrocardiographic monitoring have facilitated the introduction of new imaging techniques in the cardiac catheterization laboratory. Transesophageal echocardiography (TEE) has proved valuable for left ventricular (LV) monitoring during high-risk surgery, but its reported use in the cardiac catheterization laboratory has been limited. Accordingly, we assessed the feasibility and value of TEE during complex or high-risk coronary intervention in the catheterization laboratory. The TEE probe was successfully introduced in 53 of 54 (98%) attempted cases. The primary imaging goals were LV monitoring in 39 (74%), left main coronary artery (LMCA) imaging in 9 (17%) and both in 5 (9%) cases. LV monitoring was successful in 43 of the 44 (98%) attempted cases. In 25 (58%) of these, additional important observations were made by TEE that were not apparent by symptoms, or hemodynamic, electrocardiographic or radiographic monitoring. These included unexpected changes in regional myocardial function (n = 20), alteration in LV size (n = 2), exclusion of considered pericardial tamponade (n = 2) and detection of unsuspected mitral regurgitation (n = 1). Management of the interventional procedure was directly influenced by the findings of TEE in 11 of the 43 (26%) monitored cases. The LMCA was successfully visualized in 13 of the 14 (93%) attempted cases. In 11 of these, measurement of the stenotic lesion diameter by TEE correlated well with quantitative angiography both before (r = 0.83, standard error of the estimate = 0.01, p less than 0.002) and after (r = 0.80, standard error of the estimate = 0.03, p less than 0.005) intervention.(ABSTRACT TRUNCATED AT 250 WORDS)

Severe transient left ventricular "hypertrophy" occurring during acute myocarditis.

We report an unusual sequence of echocardiographic abnormalities observed during the course of acute myocarditis in a young woman. Striking left ventricular "hypertrophy" transiently followed the normalization of marked segmental wall motion abnormalities. These rapid and marked alterations in left ventricular wall thickness suggest that myocardial inflammation and edema resulted in the transient appearance of myocardial hypertrophy. Our findings also indicate that contractility may be nonhomogeneously depressed in acute myocarditis.

Percutaneous intraaortic balloon counterpulsation. Clinical effectiveness and hazards.

Because of its greater ease and rapidity of insertion, the percutaneous intraaortic balloon in many institutions has become the primary method for implementing counterpulsation. We report the results and complications of 113 attempted procedures in a variety of clinical settings. We had a high (93.8 percent) insertion success rate. However, our 18.6 complication rate was similar to the experience reported for the surgical method of insertion. Thus, the original anticipation of reduced complications with this method has not been realized in this and other recent reports.

Prospective evaluation of two-dimensional transthoracic echocardiography in emergency department patients with suspected pulmonary embolism.

OBJECTIVE: To prospectively examine the diagnostic accuracy of two-dimensional transthoracic echocardiography (2-D echo) in emergency department (ED) patients being evaluated for acute pulmonary embolism (PE). METHODS: This was a 14-month prospective observational trial of a convenience sample of ED patients undergoing evaluation for suspected PE at a suburban teaching hospital. The 2-D echo was defined as positive if any two of the following were noted: right ventricular dilation, abnormal septal motion, loss of right ventricular contractility, elevated pulmonary artery or right ventricular pressures, moderate to severe tricuspid regurgitation, or visualization of a clot seen in the right ventricle or pulmonary artery. The patient was considered to have a PE if one of the following was positive: a pulmonary angiogram, contrast helical computed tomography, a magnetic resonance angiogram, a high-probability ventilation/perfusion (V/Q) scan without contradictory evidence, or an intermediate-probability V/Q scan with ultrasonic evidence of deep venous thrombosis. RESULTS: Of 225 cases identified, 39 met the defined criteria for PE (17%). A 2-D echo was performed on 124 patients (55%), of whom 27 (22%) had PE. In 20 patients the 2-D echo had at least two indicators of right ventricular strain; however, only 11 of these patients had confirmed pulmonary embolus. The 2-D echo had a sensitivity of 0.41 (95% CI = 0.32 to 0.49) and a specificity of 0.91 (95% CI = 0.86 to 0.96). The likelihood ratio positive was a moderately strong 4.4, with a weak likelihood ratio negative of 0.6. CONCLUSIONS: Bedside 2-D echo is not a sensitive test for the diagnosis of PE in ED patients. Positive findings moderately increase the suspicion for PE but are not diagnostic.

Use of two-dimensional echocardiography for the diagnosis of pulmonary embolus.

We investigated the diagnostic utility of transthoracic echocardiogram (2-D ECHO) in identifying acute right heart strain in patients with suspected pulmonary embolus (PE) undergoing a pulmonary angiogram during their hospitalization. A retrospective case control study was conducted over a 3-year period at a tertiary, community teaching hospital. Patients were eligible if they had a pulmonary angiogram and a transthoracic echocardiogram. Cases were defined as an angiogram positive for PE and controls were defined as an angiogram negative for PE. We excluded cases in which the time interval between 2-D ECHO and angiogram was greater than 2 days. The 2-D ECHO was considered positive for right heart strain if two of the following were present: enlarged right ventricle, moderate or severe tricuspid regurgitation, increased right ventricular pressures, or paradoxical septal wall motion. We were able to identify 71 patients, of whom 24 met our criteria for PE. Of these, 13 had an echocardiogram consistent with our definition of acute right heart strain, for a sensitivity of 0.54. Forty-six of the 47 patients without PE did not have findings of acute right heart strain. The echocardiogram was positive in 14 patients, for a positive predictive value of 0.93. In seven patients with systolic blood pressures of less than 100 mmHg, five had a PE, all of whom met our criteria for acute right heart strain. We conclude that 2-D ECHOs show promise in identifying PE and hemodynamic compromise as a result of PE, and that further studies are warranted.

The emerging role of echocardiography in the emergency department.

Cardiac ultrasound quickly provides both anatomic and physiologic assessment of the heart at the bedside, permitting rapid diagnosis and triage of patients presenting to the emergency department with chest pain, hypotension, or dyspnea. The identification and quantification of left ventricular dysfunction by ultrasound allows effective determination of prognosis and, thus, may supplant the ECG in patient triage. Transesophageal echocardiography definitively identifies the presence of thoracic aortic dissections, and this information may be obtained more immediately than by other imaging methods. Emergency physicians should have, at a minimum, sufficient knowledge of echocardiography to know when it is applicable to a patient problem. It may be feasible for noncardiologists to gain sufficient proficiency in echocardiography to use the technique as a screening procedure in the emergency department setting.

A theoretical description of blood flow through the mitral orifice.

A nonlinear differential equation describing the Doppler velocity profile for blood flow through the mitral valve has been derived. This equation is based on fluid dynamics and a simple, but comprehensive model of atrial and ventricular mechanics. A numerical solution to the equation is described and provides excellent agreement with Doppler velocity curves obtained clinically. One important result of the theory is that in patients with mitral stenosis, the slope of the clinically observed straight-line descent of the velocity profile is proportional to the mitral orifice area and inversely proportional to the atrioventricular compliance.

Reversal of runner's bradycardia with training overstress.

OBJECTIVE: To elicit a criterion elevation (> 10%) in resting heart rate (HR) with training overstress, and subsequently test the hypothesis that such "reversed bradycardia" (RB) negatively affects running performance. DESIGN: Prospective before-and-after intervention with a comparison group. SETTING: General community. PARTICIPANTS: 21 healthy male marathon runners. INTERVENTION: Voluntary doubling of training miles on 14 consecutive days. MAIN OUTCOME MEASURES: Left ventricular (LV) function by echocardiography, HR, and plasma epinephrine (PE) at rest and during submaximal exercise, and 15 km road run performance. RESULTS: Two days after the training overstress, 12 runners met the criterion (RB group), showing an average elevation in resting HR of 16% (range: 11 to 23%). The RB group also exhibited hyperkinetic LV shortening (p < 0.05), elevated exercise HR (p < 0.001), increased PE at rest and during exercise (p < 0.05), and reduced 15 km performance (p < 0.05). The other nine runners who maintained a stable resting HR during the intervention showed no significant outcome changes. CONCLUSIONS: In addition to muscular overuse, heightened sympathetic drive likely contributed to the observed reversal of bradycardia. The development of this stress-related cardiac perturbation was associated with a decrement in running performance, confirming the hypothesis.

Peripheral nerve conduction stimulation: its effect on cardiac pacemakers.

External electromagnetic interference with cardiac pacemaker function is a recognized hazard of electronic instrumentation used for diagnosis or therapy. Although improved shielding and circuitry have made newer pacemakers less vulnerable to extraneous electronic artifact, their increasing use may expose more patients to the complications of electromagnetic interference. The effects of nerve conduction stimulation testing (NCST) on patients with cardiac pacemakers were evaluated both clinically and in the laboratory. Estimates of interference potentials likely to occur at a pacemaker input during NCST were made by making calculations from a theoretical model. For three different pacemakers, these estimates were compared to laboratory tests of sensitivity to interference. Some potential for pacemaker interference was shown to exist, although primarily with unipolar pacing leads. Twenty patients, five of whom were monitored electrocardiographically, underwent uneventful nerve conduction studies. Although pulse producing stimulators have the potential to affect demand type pacemakers, if current paths are confined within standard clinical parameters, untoward responses appear unlikely.

Intracoronary streptokinase in clinical practice.

The candidacy for streptokinase (SK) infusion was studied in 95 patients displaying ECG evidence of acute or impending infarction who were catheterized within 5 hours of the onset of chest pain. Intracoronary SK was administered to 84 patients in whom occlusions of the infarct-related vessel were identified, with early recanalization having been achieved in 74 (88%). Because of completeness of studies, a data base of 72 patients was employed for further analysis. Recanalization was sustained at follow-up in 45 of 55 patients (82%). Spontaneous thrombolysis was demonstrated at follow-up in five patients (8%) initially resistant to SK, and rethrombosis occurred in 10 patients (18%). Preservation of R waves relative to Q wave depth was limited to patients with less than 90% residual stenosis. Eight of nine patients with continuing thrombolysis and patients with recanalized occlusions of the left anterior descending coronary artery displayed more impressive increases in mean (+/- SEM) ejection fraction (47% +/- 4% to 53% +/- 5% [p less than 0.05], and 47% +/- 3% to 52% +/- 5, respectively). The ejection fraction also increased significantly in 15 patients with pre-SK values of less than 50% (41% +/- 2% to 48% +/- 3%; p less than 0.05). Ventricular function deteriorated in SK failures. Reperfusion arrhythmias occurred in 28 of 62 recanalized patients (45%). Minor bleeding tendencies were displayed in 18 of 72 patients (25%). Major hemorrhages, one of which may have been fatal, occurred in four patients (5.6%). Of 84 patients, four (4.7%) died, two of whom were in cardiogenic shock when first seen. In contrast, there were 11 deaths (11.8%) in a consecutive simultaneously enrolled series of 93 control patients with similar entry criteria (p less than 0.05). Two additional SK-treated patients died, 16 and 30 days after treatment, both more than a week after surgical revascularization. It is concluded that SK recanalization is a promising new therapy that may decrease mortality and preserve myocardial function in certain circumstances. Its efficacy in a setting closer to the mainstream of cardiologic practice extends the favorable experience issuing from earlier clinical investigations.

Contribution of transesophageal echocardiography to patient diagnosis and treatment: a prospective analysis.

The capability of transesophageal (TEE) versus transthoracic (TTE) echocardiography as a diagnostic tool in clinical practice was prospectively examined in 86 consecutive cases. A conclusive diagnosis was possible in 95% with TEE, whereas the same result was achieved in 48% by TTE. Specifically, TEE provided a conclusive diagnosis in 14 of 16 cases of infective endocarditis, while TTE gave this result in 4 of the 16 cases (p less than 0.001). Similarly, TEE allowed a conclusive diagnosis in 11 of 11 instances of aortic dissection, while TTE gave this indication in two cases (p less than 0.001). TEE was similarly effective in eight of eight cases of atrial thrombi, whereas TTE gave the diagnosis in three of eight cases (p less than 0.01). In five subjects with intracardiac masses, TEE gave a conclusive diagnosis in all five, whereas TTE was able to diagnose conclusively in one subject (p less than 0.02). In seven patients with mitral regurgitation, TEE gave the conclusive diagnosis in all seven and TTE was able to provide this information in four (p = NS). TEE was able to provide a conclusive diagnosis in four patients with aortic insufficiency, and TTE gave the same information in two of the four (p = NS). In 14 patients with prosthetic valve dysfunction, TEE gave the diagnosis in 12 and TTE gave it in eight patients (p = NS). Both methods gave a conclusive diagnosis in 13 out of 13 cases of mitral stenosis (p = NS). Also, TEE provided a conclusive diagnosis in eight of eight patients with adult congenital heart disease and TTE gave this information in four (p = NS).(ABSTRACT TRUNCATED AT 250 WORDS)

Symmetric cardiac enlargement in highly trained endurance athletes: a two-dimensional echocardiographic study.

Twelve highly trained male endurance athletes and 12 normally active matched control subjects were studied by two-dimensional and M-mode echocardiography to evaluate changes in the right and left heart chambers associated with intense aerobic training. Maximal oxygen uptake, a measure of cardiovascular fitness, ranged from 62.1 to 82.6 ml/kg/min in the athletes and from 33.0 to 49.3 ml/kg/min in the control subjects (p less than 0.001). The athletes had significantly greater left ventricular wall thickness (p less than 0.01), left ventricular chamber area (p less than 0.005), left atrial area (p less than 0.01), right ventricular chamber area (p less than 0.002), right ventricular wall thickness (p less than 0.05), and right atrial area (p less than 0.01). Proportionality of cardiac chamber enlargement in the athletes was shown by similar ratios of both right-to-left ventricular areas and right-to-left atrial areas in the two groups. Left ventricular contractility was not significantly different between groups. Cardiac enlargement in endurance athletes enables a greater stroke volume for the performance of sustained, intense exercise; hypertrophy of the chamber walls normalizes wall stress. These changes occur symmetrically in both right and left cardiac chambers in the endurance athlete, reflecting bilateral hemodynamic loading. The symmetry of the endurance athlete's cardiac enlargement differs from most pathologic conditions which have heterogeneous effects on specific cardiac chambers.